Observational studyClinical orthopaedics and related research2022
What is the Elbow Flexion Strength After Free Functional Gracilis Muscle Transfer for Adult Traumatic Complete Brachial Plexus Injuries?
Observational study in Clinical orthopaedics and related research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
- CORR Insights®: What is the Elbow Flexion Strength After Free Functional Gracilis Muscle Transfer for Adult Traumatic Complete Brachial Plexus Injuries?Clinical orthopaedics and related research · 2022Article
Corrections and comments
- Commented on by
Authors and funding
6 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTraumatic brachial plexus injuries (BPIs) in the nerve roots of C5 to T1 lead to the devastating loss of motor and sensory function in the upper extremity. Free functional gracilis muscle transfer (FFMT) is used to reconstruct elbow and shoulder function in adults with traumatic complete BPIs. The question is whether the gains in ROM and functionality for the patient outweigh the risks of such a large intervention to justify this surgery in these patients. QUESTIONS/PURPOSES: (1) After FFMT for adult traumatic complete BPI, what is the functional recovery in terms of elbow flexion, shoulder abduction, and wrist extension (ROM and muscle grade)? (2) Does the choice of distal insertion affect the functional recovery of the elbow, shoulder, and wrist? (3) Does the choice of nerve source affect elbow flexion and shoulder abduction recovery? (4) What factors are associated with less residual disability? (5) What proportion of flaps have necrosis and do not reinnervate?
methodsWe performed a retrospective observational study at Dr. Soetomo General Hospital in Surabaya, Indonesia. A total of 180 patients with traumatic BPIs were treated with FFMT between 2010 and 2020, performed by a senior orthopaedic hand surgeon with 14 years of experience in FFMT. We included patients with traumatic complete C5 to T1 BPIs who underwent a gracilis FFMT procedure. Indications were total avulsion injuries and delayed presentation (>6 months after trauma) or after failed primary nerve transfers (>12 months). Patients with less than 12 months of follow-up were excluded, leaving 130 patients eligible for this study. The median postoperative follow-up period was 47 months (interquartile range [IQR] 33 to 66 months). Most were men (86%; 112 of 130) who had motorcycle collisions (96%; 125 patients) and a median age of 23 years (IQR 19 to 34 years). Orthopaedic surgeons and residents measured joint function at the elbow (flexion), shoulder (abduction), and wrist (extension) in terms of British Medical Research Council (MRC) muscle strength scores and active ROM. A univariate analysis of variance test was used to evaluate these outcomes in terms of differences in distal attachment to the extensor carpi radialis brevis (ECRB), extensor digitorum communis and extensor pollicis longus (EDC/EPL), the flexor digitorum profundus and flexor pollicis longus (FDP/FPL), and the choice of a phrenic, accessory, or intercostal nerve source. We measured postoperative function with the DASH score and pain at rest with the VAS score. A multivariate linear regression analysis was performed to investigate what patient and injury factors were associated with less disability. Complications such as flap necrosis, innervation problems, infections, and reoperations were evaluated.
resultsThe median elbow flexion muscle strength was 3 (IQR 3 to 4) and active ROM was 88° ± 46°. The median shoulder abduction grade was 3 (IQR 2 to 4) and active ROM was 62° ± 42°. However, the choice of distal insertion was not associated with differences in the median wrist extension strength (ECRB: 2 [IQR 0 to 3], EDC/EPL: 2 [IQR 0 to 3], FDP/FPL: 1 [IQR 0 to 2]; p = 0.44) or in ROM (ECRB: 21° ± 19°, EDC/EPL: 21° ± 14°, FDP/FPL: 13° ± 15°; p = 0.69). Furthermore, the choice of nerve source did not affect the mean ROM for elbow flexion (phrenic nerve: 87° ± 46°; accessory nerve: 106° ± 49°; intercostal nerves: 103° ± 50°; p = 0.55). No associations were found with less disability (lower DASH scores): young age (coefficient = 0.28; 95% CI -0.22 to 0.79; p = 0.27), being a woman (coefficient = -9.4; 95% CI -24 to 5.3; p = 0.20), and more postoperative months (coefficient = 0.02; 95% CI -0.01 to 0.05]; p = 0.13). The mean postoperative VAS score for pain at rest was 3 ± 2. Flap necrosis occurred in 5% (seven of 130) of all patients, and failed innervation of the gracilis muscle occurred in 4% (five patients).
conclusionFFMT achieves ROM with fair-to-good muscle power of elbow flexion, shoulder abduction, and overall function for the patient, but does not achieve good wrist function. Meticulous microsurgical skills and extensive rehabilitation training are needed to maximize the result of FFMT. Further technical developments in distal attachment and additional nerve procedures will pave the way for reconstructing a functional limb in patients with a flail upper extremity. LEVEL OF EVIDENCE: Level III, therapeutic study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.